予測的疾患分析の世界市場：市場規模・シェア・動向分析 (コンポーネント別・展開方式別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

予測的疾患分析市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の予測的疾患分析の市場規模は2030年までに102億米ドルに達し、2025年から2030年にかけて22.7％のCAGRで拡大すると予測されています。

予測的疾患分析は、データ主導の質の高いケア、正確な診断、個別化された治療を提供するために、医療機関、病院、医師が患者データを分析・処理するために使用するソフトウェアソリューションを指します。予測分析は、医療における患者の転帰を向上させる高度な手法です。

さらに、予測分析ソリューションは、医療提供者が疾病の蔓延、疾病管理、リスク管理と軌跡を理解し、最適な転帰のために患者に適切な医療を提供するために使用されます。医療提供者は、個人の健康に対するリスク率を評価するだけでなく、将来の転帰を予測して準備するためにこれを使用します。不必要な出費を避けるための様々なレベルでの利用も、この技術の利用を増加させており、これは予測期間を通じて継続すると予測されています。その結果、世界の予測的疾患分析市場は成長すると予想されます。

予測分析は、COVID-19問題に対抗し、患者の予後不良の発生率を低下させ、危機時のリソース管理に対処する上で重要な役割を果たしています。大流行中に作成された大量の患者データは、アナリティクス企業や医療部門に、病気の広がりを適切に分析するためのデータを提供しただけでなく、リソース配分にも役立ちました。病院を含むいくつかの開発機関では、患者が重篤な症状を発症する確率、感染症／疾患の軌跡、その他いくつかのパラメーターを決定するために予測分析を使用していました。例えば、2020年、米国のクリーブランド・クリニックの研究者は、個人の陽性となる確率を予測する自動分析モデルを作成しました。それゆえ、市場の成長を後押ししています。

世界市場は、慢性疾患の負担の増加、個別化医療とエビデンスに基づく医療の出現、医療部門における効率化のニーズの高まり、不必要なコストを排除して医療費を削減する需要の高まりの結果、急速に拡大しています。疾病管理センターによると、アメリカ人の10人中6人は、心臓病や脳卒中、がん、糖尿病など、少なくとも1つの慢性疾患を抱えています。したがって、製品需要が増加し、市場成長がさらに促進されます。

市場成長を促進するもう一つの重要な理由は、適切な患者に適切な治療を提供するためのエビデンスに基づく医療の利用です。患者記録のための電子カルテ（EHR）の利用は近年増加しており、勤務医の場合、EHRの採用率は2008年の42％から、米国では2021年には88％近くまで増加しています。医療予測分析では、EHRを活用して、治療や投薬の際に最適な方針を推奨します。これは患者のコストを大幅に削減するだけでなく、転帰の改善にもつながります。電子医療システム、分析ツール、人工知能（AI）の採用が市場開拓の原動力になると予想されます。世界レベルで慢性疾患の負担が増加しているため、医療にかかる費用は年々上昇しています。

予測的疾患分析市場の各社は、製品・サービスポートフォリオを継続的に拡充し、開発を加速させています。例えば、2022年6月、ヘルスコンサルタント会社であるEngagys LLCは、医療システム、ヘルスプラン、医療技術のリーダー向けの新しい手頃な価格のサブスクリプションサービスのデビューを発表しました。エグゼクティブ・アドバイザリー・サービスは、医療の顧客エンゲージメント担当者に、実践的で実用的なガイダンス、洞察、ベストプラクティスを提供することを目的としています。これにより、予測分析ソリューションにおける同社の地位が強化され、市場成長がさらに促進されることが期待されます。

予測的疾患分析市場：分析概要

• 予測期間中、クラウドベースのソリューションのCAGRが最も高くなると予測されます。ストレージの容易さ、安価な資本要件、柔軟性の向上、効率性がその開発の要因です。
• 最終用途別では、医療支払者セグメントが2023年の市場を独占しました。保険会社、医療プランのスポンサー、その他の第三者支払者などの支払者は、医療環境における予測分析の主要な受益者の1つです。したがって、このセグメントの成長を後押ししています。
• 北米では、慢性疾患の有病率が上昇し、予防健康に対する意識が高まり、老年人口の割合が増加しているため、この地域が最大の市場シェアを占めています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 予測的疾患分析市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 予測的疾患分析市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
  • 規制の枠組み
  • 新興技術の動向
  • ケーススタディと洞察
  • COVID-19の影響分析

第4章 予測的疾患分析市場：コンポーネント別の推定・動向分析

• セグメントダッシュボード
• 世界の予測的疾患分析の変動分析：コンポーネント別
• 世界の予測的疾患分析の市場規模と動向分析：コンポーネント別（2018～2030年）
• ソフトウェア・サービス市場
• ハードウェア市場

第5章 予測的疾患分析市場：展開方式別の推定・動向分析

• セグメントダッシュボード
• 世界の予測的疾患分析の変動分析：展開方式別
• 世界の予測的疾患分析の市場規模と動向分析：展開方式別（2018～2030年）
• オンプレミス市場
• クラウドベースの市場

第6章 予測的疾患分析市場：最終用途別の推定・動向分析

• セグメントダッシュボード
• 世界の予測的疾患分析の変動分析、最終用途別
• 世界の予測的疾患分析の市場規模と動向分析：最終用途別（2018～2030年）
• 医療支払者
• 医療提供者
• その他のエンドユーザー

第7章 予測的疾患分析市場：地域別の推定・動向分析

• 市場シェア分析：地域別（2024年・2030年）
• 市場ダッシュボード：地域別
• 市場規模の予測と動向分析（2018～2030年）
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業/競合の分類
• 企業市況分析（2024年）
• 企業プロファイル/上場企業
  • Oracle
  • Cerner Corporation
  • IBM
  • SAS
  • Allscripts Healthcare Solutions Inc.
  • MedeAnalytics, Inc.
  • Health Catalyst
  • Apixio Inc
  • GE Healthcare（a division of General Electric Company）
  • Siemens Healthineers

List of Tables

• Table 1 List of abbreviation
• Table 2 North America Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
• Table 3 North America Predictive disease analytics market, by component, 2018 - 2030 (USD Million)
• Table 4 North America Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 5 North America Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 6 U.S. Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 7 U.S. Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 8 U.S. Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 9 Canada Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 10 Canada Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 11 Canada Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 12 Mexico Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 13 Mexico Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 14 Mexico Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 15 Europe Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
• Table 16 Europe Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 17 Europe Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 18 Europe Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 19 UK Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 20 UK Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 21 UK Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 22 Germany Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 23 Germany Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 24 Germany Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 25 France Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 26 France Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 27 France Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 28 Italy Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 29 Italy Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 30 Italy Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 31 Spain Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 32 Spain Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 33 Spain Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 34 Denmark Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 35 Denmark Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 36 Denmark Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 37 Sweden Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 38 Sweden Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 39 Sweden Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 40 Norway Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 41 Norway Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 42 Norway Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 47 China Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 48 China Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 49 China Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 50 Japan Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 51 Japan Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 52 Japan Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 53 India Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 54 India Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 55 India Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 56 South Korea Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 57 South Korea Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 58 South Korea Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 59 Australia Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 60 Australia Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 61 Australia Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 62 Thailand Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 63 Thailand Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 64 Thailand Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 65 Latin America Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
• Table 66 Latin America Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 67 Latin America Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 68 Latin America Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 69 Brazil Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 70 Brazil Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 71 Brazil Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 72 Argentina Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 73 Argentina Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 74 Argentina Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 75 MEA Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
• Table 76 MEA Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 77 MEA Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 78 MEA Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 79 South Africa Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 80 South Africa Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 81 South Africa Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 85 UAE Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 86 UAE Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 87 UAE Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
• Table 88 Kuwait Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
• Table 89 Kuwait Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
• Table 90 Kuwait Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 Predictive disease analytics market: Market outlook
• Fig. 5 Predictive disease analytics market: Segment outlook
• Fig. 6 Predictive disease analytics market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 Predictive disease analytics market driver impact
• Fig. 9 Predictive disease analytics market restraint impact
• Fig. 10 Predictive disease analytics market: Component outlook and key takeaways
• Fig. 11 Predictive disease analytics market: Component movement analysis
• Fig. 12 Software & Services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 13 Hardware market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 14 Predictive disease analytics market: Deployment Mode outlook and key takeaways
• Fig. 15 Predictive disease analytics market: Deployment Mode movement analysis
• Fig. 16 On-premise market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 17 Cloud-based market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 18 Predictive disease analytics market: End User outlook and key takeaways
• Fig. 19 Predictive disease analytics market: End User movement analysis
• Fig. 20 Healthcare Payers Market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 21 Healthcare Providers Market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 22 Other End Users market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 23 Global Predictive disease analytics market: Regional outlook and key takeaways
• Fig. 24 Global Predictive disease analytics market: Regional movement analysis
• Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Key country dynamics
• Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Key country dynamics
• Fig. 29 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Key country dynamics
• Fig. 31 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Key country dynamics
• Fig. 34 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Key country dynamics
• Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Key country dynamics
• Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Key country dynamics
• Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Key country dynamics
• Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Key country dynamics
• Fig. 44 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Key country dynamics
• Fig. 46 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Key country dynamics
• Fig. 48 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Key country dynamics
• Fig. 53 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Key country dynamics
• Fig. 66 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Key country dynamics
• Fig. 69 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Key country dynamics
• Fig. 71 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Key country dynamics
• Fig. 73 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Predictive Disease Analytics Market Growth & Trends:

The global predictive disease analytics market size is expected to reach USD 10.2 billion by 2030 and is expected to expand at 22.7% CAGR from 2025 to 2030, according to a new report by Grand View Research, Inc. Predictive disease analytics refers to software solutions used by healthcare organizations, hospitals, and physicians to analyze and process patient data in order to provide data-driven, high-quality care, precise diagnostics, and individualized treatments. Predictive analytics is an advanced method to enhance patient outcomes in healthcare.

Additionally, predictive analytics solutions are used by healthcare providers to comprehend disease prevalence, disease management, risk management & trajectories, and to provide suitable medical care to patients for optimal outcomes. Healthcare providers use it to evaluate the risk rate to an individual's health as well as predict future outcomes in preparation. Its use at various levels to avoid unnecessary expenditure had also increased the utilization of this technology, which is anticipated to continue throughout the forecast period. As a result, the global predictive disease analytics market is expected to grow.

Predictive analytics has played a significant part in combating COVID-19 problems, decreasing the incidence of poor outcomes for patients, and addressing resource management during the crisis. The massive amount of patient data produced during the outbreak not only provided analytics firms and the healthcare sector with data to properly analyze disease spread, but it also aided in resource allocation. Several institutions, including hospitals, was using predictive analytics to determine the probability of a patient developing severe symptoms, the trajectory of their infection/disease, and several other parameters. For instance, in 2020, researchers at the Cleveland Clinic in the U. S. created an automated analytics model that predicted an individual's chance of testing positive. Hence, propelling the market growth.

The global market is expanding rapidly as a result of the increasing burden of chronic diseases, the emergence of personalized and evidence-based medicine, the growing need for increased efficiency in the healthcare sector, and the growing demand to reduce healthcare costs by eliminating unnecessary costs. As per the center for disease control, six out of every ten Americans have at least one chronic illness, such as heart disease or stroke, cancer, or diabetes. Hence, it will increase the product demand and further boost the market growth.

Another important reason driving market growth is the use of evidence-based medicine to provide the right kind of treatment to the right patient. The utilization of Electronic Health Records (EHRs) for patient records has increased in recent years, with adoption of EHRs in the case of office-based doctors increasing from 42% in 2008 to nearly 88% in 2021 in the U. S. Healthcare predictive analytics makes use of EHRs to recommend the best course of action in the event of a medical treatment or medication. This not only greatly reduces patient costs but also leads to improved outcomes. The adoption of electronic health systems, analytics tools, and artificial intelligence (AI) are expected to drive market development. The expense of healthcare has risen over the years owing to the increasing burden of chronic diseases on a global level.

The companies in the predictive disease analytics market are continuously expanding their product and services portfolio to accelerate the development of the product. For instance, in June 2022, Engagys LLC, a Health Consultant Company, announced the debut of a new affordable subscription service for healthcare systems, health plans, & healthcare technology leaders. Executive Advisory Services is intended to provide healthcare customer engagement practitioners with practical and actionable guidance, insights, and best practices that they can put to use immediately. This is expected to strengthen the company's position in predictive analytics solution and further boost the market growth.

Predictive Disease Analytics Market Report Highlights:

• Cloud-based solutions are anticipated to have the highest CAGR during the forecast period. The ease of storage, inexpensive capital requirements, increased flexibility, and efficiency are attributed to its development.
• On the basis of end user, payer segment dominated the market in 2023.Payers, such as insurance firms, health plan sponsors, as well as other third-party payers, are among the primary beneficiaries of predictive analytics in healthcare settings. Thus, boosting the segment growth.
• Due to the rising prevalence of chronic diseases, greater awareness of preventive health and rising percentage of geriatric population in North America, the region had the largest market share.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Component Type Segment
  • 1.2.2. Deployment Segment
  • 1.2.3. End User Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Predictive Disease Analytics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rise in government initiatives and an increasing amount of money being invested in the healthcare industry
    • 3.2.1.2. Technological advancements in AI and machine learning
    • 3.2.1.3. Increasing prevalence of chronic diseases
    • 3.2.1.4. Growing shift towards personalized medicine
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Growing data privacy concerns
    • 3.2.2.2. Lack of skilled professionals
    • 3.2.2.3. High implementation cost
• 3.3. Predictive disease analytics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Technological Landscape
    • 3.3.2.3. Economic Landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal Landscape
    • 3.3.2.6. Social Landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Emerging Technologies Trends
  • 3.3.5. Case Study & Insights
    • 3.3.5.1. Use Cases
  • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Predictive Disease Analytics Market: Component Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Predictive Disease Analytics Movement Analysis
• 4.3. Global Predictive Disease Analytics Market Size & Trend Analysis, by Component, 2018 - 2030 (USD Million)
• 4.4. Software and Services Market
  • 4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
• 4.5. Hardware Market
  • 4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Predictive Disease Analytics Market: Deployment Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Predictive Disease Analytics Movement Analysis
• 5.3. Global Predictive Disease Analytics Market Size & Trend Analysis, by Component, 2018 - 2030 (USD Million)
• 5.4. On-premise Market
  • 5.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
• 5.5. Cloud-based Market
  • 5.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Predictive Disease Analytics Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Predictive Disease Analytics Market End Use Movement Analysis
• 6.3. Global Predictive Disease Analytics Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
• 6.4. Healthcare Payers
  • 6.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
• 6.5. Healthcare Providers
  • 6.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
• 6.6. Other End Users
  • 6.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Predictive Disease Analytics Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2018 - 2030:
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Competitive scenario
    • 7.5.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Company Market Position Analysis, 2024
• 8.3. Company Profiles/Listing
  • 8.3.1. Oracle
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Cerner Corporation
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. IBM
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. SAS
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Allscripts Healthcare Solutions Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. MedeAnalytics, Inc.
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Health Catalyst
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Apixio Inc
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. GE Healthcare (a division of General Electric Company)
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Siemens Healthineers
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives